Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
SK BIOSCIENCE
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
June 9, 2026
SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access
June 2, 2026
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
May 29, 2026
SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America
May 26, 2026
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
March 18, 2026
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
February 4, 2026
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 30, 2026
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 23, 2026